How and why the drugs have such wide-ranging health benefits is subject to further research, and the GLP-1 drugs were found ... for cravings—the same mechanism that could contribute to weight ...

Altimmune, Inc. (NASDAQ:ALT), a biopharmaceutical company with a market capitalization of $503.56 million focused on ...

One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

Coya Therapeutics, Inc. (NASDAQ:COYA) announced the expansion of its investigational pipeline and advancement of COYA 303 for ...

Tirzepatide includes blockbuster injected GLP-1 medications Mounjaro (for diabetes ... is 90 days away (March 19), the FDA said in a statement. “FDA may still take action regarding violations of any ...

GLP-1 medications associated with lower risks of Alzheimer's and heart disease, but higher risks of pancreatitis and kidney ...

Scientists may have identified a way to naturally regulate blood sugar levels and sugar cravings in a similar fashion to ...

Last month, the European Medicines Agency allowed Novo to add risk reduction for events related to kidney disease to the ...

With promising therapeutic effects comes an increased scrutiny on side effects. GLP-1 receptor agonists mimic the action of the native GLP-1 peptide, enhancing insulin secretion, suppressing glucagon ...

NEW YORK — Popular GLP-1 medications approved for weight loss ... After waiting over eight months for a refund from a medical clinic, an ABC Action News viewer reached out to consumer ...